Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Just a typical Drop
View:
Post by RoboticSlave on Apr 09, 2021 3:57pm

Just a typical Drop

Oncolytics is a stock that likes to be played with, get it up to $5-$6 and then tank it back to $3.50, not bad if you play your cards right, but eventually it will get to $5-$6 and then skyrocket up, but I sold some mid-$5 and kept some, don't wanna miss out when the rocket does actually launch
Comment by Korcan on Apr 09, 2021 7:52pm
This post has been removed in accordance with Community Policy
Comment by askretka on Apr 10, 2021 3:23pm
Probably just normal profit taking. Remember some people just buy and sell based on charts and momentum without ever doing any research about what they are investing in. Car-T and Pelareorep is z new story and its still just animal testing and some analysts are giving it no value to their research reports but I think if we get Phase 3 breast cancer and any kind of CAR-T Pelareorep study the stock ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities